Point32Health prior authorization criteria
Submission criteria, documentation packets, and P2P prep by drug — for prescribers and PA staff. 30-day standard PA decision.
Point32Health reviews prior-authorization requests against its published medical policies — diagnosis with ICD-10 code, documented step-therapy history, and prescriber attestation of medical necessity. Standard PA decisions return in 30 days; if denied, prescribers and members have 180 days to appeal. Criteria by drug below.
Prior authorization criteria by drug
Each page covers Point32Health's submission criteria, the documentation packet, and peer-to-peer prep for that drug.
- Adalimumab at Point32Health →
- Aflibercept at Point32Health →
- Apixaban at Point32Health →
- Atezolizumab at Point32Health →
- Atogepant at Point32Health →
- Benralizumab at Point32Health →
- Bevacizumab at Point32Health →
- Bictegravir at Point32Health →
- Buprenorphine at Point32Health →
- Dapagliflozin at Point32Health →
- Dulaglutide at Point32Health →
- Dupilumab at Point32Health →
- Eculizumab at Point32Health →
- Elexacaftor Tezacaftor Ivacaftor at Point32Health →
- Empagliflozin at Point32Health →
- Erenumab at Point32Health →
- Evolocumab at Point32Health →
- Faricimab at Point32Health →
- Fingolimod at Point32Health →
- Fremanezumab at Point32Health →
- Galcanezumab at Point32Health →
- Glecaprevir Pibrentasvir at Point32Health →
- Guselkumab at Point32Health →
- Ibrutinib at Point32Health →
- Imatinib at Point32Health →
- Inclisiran at Point32Health →
- Infliximab at Point32Health →
- Ixekizumab at Point32Health →
- Lenalidomide at Point32Health →
- Liraglutide at Point32Health →
- Lisdexamfetamine at Point32Health →
- Mepolizumab at Point32Health →
- Methylphenidate at Point32Health →
- Naltrexone at Point32Health →
- Natalizumab at Point32Health →
- Nintedanib at Point32Health →
- Nivolumab at Point32Health →
- Nusinersen at Point32Health →
- Ocrelizumab at Point32Health →
- Ofatumumab at Point32Health →
- Omalizumab at Point32Health →
- Ozanimod at Point32Health →
- Palbociclib at Point32Health →
- Pembrolizumab at Point32Health →
- Pirfenidone at Point32Health →
- Ribociclib at Point32Health →
- Rimegepant at Point32Health →
- Risankizumab at Point32Health →
- Rituximab at Point32Health →
- Rivaroxaban at Point32Health →
- Sacubitril Valsartan at Point32Health →
- Secukinumab at Point32Health →
- Semaglutide at Point32Health →
- Sofosbuvir at Point32Health →
- Tafamidis at Point32Health →
- Tenofovir Alafenamide at Point32Health →
- Tezepelumab at Point32Health →
- Tirzepatide at Point32Health →
- Tofacitinib at Point32Health →
- Trastuzumab at Point32Health →
- Upadacitinib at Point32Health →
- Ustekinumab at Point32Health →
Generate a Point32Health PA packet
Open ApprovalHelp — generate a prior-auth packet tailored to Point32Health's criteria, with prescriber attestation and step-therapy documentation pre-filled.
Get started →Contact: hello@approvalhelp.com